Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the microrna market right now?

The scale of the microrna market has seen a significant increase recently, with projections showing it expanding from $1.33 billion in 2024 to $1.58 billion in 2025, maintaining a compound annual growth rate (CAGR) of 18.9%. The growth witnessed in the past years can be traced back to factors such as the discovery of microRNAs, RNA interference (RNAi), genome sequencing efforts, the rise of computational biology and bioinformatics, and research into extracellular vehicles (EVs).

How fast Is the microrna market expected to grow, and what’s its future value?

In the forthcoming years, the microrna market is projected to experience an accelerated growth, reaching $3.11 billion in 2029 with a compound annual growth rate (CAGR) of 18.5%. Clinical translation, regulatory networks, systems biology, microRNA-centered therapeutics, potential therapies, and discovery of biomarkers are factors propelling the growth in this forecast phase. The key trends during this period are likely to involve technological enhancements, bioinformatics, data interpretation, conservation across species, interactions within the microbiome, and operative mechanisms.

Get your microrna market report here!

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

What are the leading drivers of growth in the microrna market?

The growth of the microRNA market is being fuelled by the rise in cancer incidences. Cancer is a multifaceted disease that is characterized by the unregulated growth and proliferation of cells, which often results in the creation of malignant tumors that can infest neighbouring tissues and metastasize to distant organs, creating serious health hazards. A multitude of factors such as an aging population, unhealthy lifestyle choices like smoking and suboptimal diet, exposure to environmental pollutants, and enhanced detection techniques that allow for early diagnosis are contributing to the rise in cancer cases. MicroRNA is used in conjunction with standard cancer treatments to improve drug responsiveness and elevate patient outcomes. MiRNAs function not only as a means of treatment but also as diagnostic and prognostic biomarkers, aiding in the identification of cancer types, forecasting disease progression, and supervising treatment responses. As an example, the National Cancer Institute, a governmental organization based in the US, disclosed that around 20 million new cases and 9.7 million cancer-related deaths were logged annually in 2022. Projections suggest that by 2040, there will be roughly 15.3 million deaths and 29.9 million new cases annually. As such, the escalating amount of cancer cases are accelerating the expansion of the microRNA market.

What are the key segments defining the microrna market?

The microrna market covered in this report is segmented –

1) By Products: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

Who are the key players steering the development of the microrna market?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

What are the key trends shaping the future of the microrna market?

Leading firms in the microRNA market are honing in on creating sophisticated solutions like MiRNA probe customization services to cater to the unique requirements of scientists and clinicians, improve miRNA detection precision, and support a broad array of applications. MiRNA probe customization services are specialist services provided by biotech and molecular biology companies to design and generate bespoke probes for individual microRNAs (miRNAs), useful in diverse research and clinical uses. In September 2023, for example, Abnova Corporation, a biotech firm from Taiwan, introduced upgraded customization services for miRNA probes and a new series of cataloged miRNA probes, aimed at satisfying the varying needs of the academic, industrial, and research sections involved in miRNA research. These probes are indispensable in pinpointing and accurately locating miRNAs, small, non-coding RNA molecules vital for different biological processes. Abnova’s customization services promise high precision and low cross-reactivity, making them ideal for analyzing samples with scarce miRNA content.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

Which regions are most influential in expanding the microrna market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Physical Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Mycoplasma Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: